Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rafael Berlezi Machado"'
Autor:
Caroline Vieira Spessotto, Hanaie Cavalli, Audred Cristina Biondo Eboni, Rafael Berlezi Machado, Analara Munardi Mousquer, Lara Both Palazzo, Alessandro Finkelsztejn, Marcus Vinicius Magno Goncalves, Henry Koiti Sato, Fabio Siquineli, Yara Dadalti Fragoso
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 74, Iss 8, Pp 617-620 (2016)
ABSTRACT Objective The treatment of multiple sclerosis (MS) with disease-modifying-drugs (DMDs) is evolving and new drugs are reaching the market. Efficacy and safety aspects of the drugs are crucial, but the patients’ satisfaction with the treatme
Externí odkaz:
https://doaj.org/article/57dfa6d9fe09454f891f60065b92a574
Autor:
Henry Koiti Sato, Analara Munardi Mousquer, Fabio Siquineli, Caroline Vieira Spessotto, Lara Both Palazzo, Marcus Goncalves, Yara Dadalti Fragoso, Alessandro Finkelsztejn, Hanaie Cavalli, Audred Cristina Biondo Eboni, Rafael Berlezi Machado
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 74, Iss 8, Pp 617-620 (2016)
Arquivos de Neuro-Psiquiatria v.74 n.8 2016
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Volume: 74, Issue: 8, Pages: 617-620, Published: AUG 2016
Arquivos de Neuro-Psiquiatria v.74 n.8 2016
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Volume: 74, Issue: 8, Pages: 617-620, Published: AUG 2016
Objective The treatment of multiple sclerosis (MS) with disease-modifying-drugs (DMDs) is evolving and new drugs are reaching the market. Efficacy and safety aspects of the drugs are crucial, but the patients’ satisfaction with the treatment must b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb2c690567cba77478b1c4c445e0de99
https://pubmed.ncbi.nlm.nih.gov/27556371
https://pubmed.ncbi.nlm.nih.gov/27556371